ADAM MONTERO: Open Payments
NPI 1740412055 · OKEMOS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$399 in 18 payments from 11 companies in 2025. Trend: 2023 $188 · 2024 $134 · 2025 $399
Food & beverage: $399
| Company | Payments | Amount |
|---|---|---|
| LeMaitre Vascular, Inc. | 3 | $99 |
| Abbott Laboratories | 4 | $78 |
| Lilly USA, LLC | 2 | $42 |
| Novo Nordisk Inc | 2 | $31 |
| ABBVIE INC. | 1 | $26 |
| Ascensia Diabetes Care Us Inc. | 1 | $25 |
| PFIZER INC. | 1 | $22 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $18 |
Products named: FREESTYLE LIBRE 3, ARTEGRAFT VASCULAR GRAFT, MOUNJARO, HYDRO LEMAITRE VALVULOTOME, VRAYLAR, PREVNAR 20, NEFFY, REXULTI.
Industry payments across MI — which companies pay providers there.
